You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Moderate to Severe Pruritus

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pruritus, Notalgia Paresthetica Trial in Coral Gables (difelikefalin 2.0 mg tablets, difelikefalin 1.0 mg tablets, difelikefalin

Recruiting
  • Pruritus
  • Notalgia Paresthetica
  • difelikefalin 2.0 mg tablets
  • +3 more
  • Coral Gables, Florida
    Cara Therapeutics Study Site
Aug 3, 2023

Pruritus Trial in Jacksonville (Dupilumab 300Mg Solution for Injection)

Recruiting
  • Pruritus
  • Dupilumab 300Mg Solution for Injection
  • Jacksonville, Florida
    Mayo Clinic Florida
Nov 30, 2022

Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)

Recruiting
  • Chronic Kidney Diseases
  • Pruritus
  • Difelikefalin 1 mg Oral Tablet
  • Placebo Oral Tablet
  • Northridge, California
  • +5 more
Dec 21, 2022

Uremic Pruritus Trial in China (Difelikefalin Injection, Placebo Injection)

Recruiting
  • Uremic Pruritus
  • Difelikefalin Injection
  • Placebo Injection
  • Baotou, China
  • +34 more
Jun 1, 2023

Lichen Simplex Chronicus Trial in Bensheim, Berlin (drug, diagnostic test, procedure, other)

Recruiting
  • Lichen Simplex Chronicus
  • IMP Application KM-001
  • +12 more
  • Bensheim, Germany
  • +1 more
Jul 7, 2022

Pruritus, Atopic Dermatitis Trial (difelikefalin 0.25 mg, difelikefalin 0.5 mg, TCS Cream)

Recruiting
  • Pruritus
  • Atopic Dermatitis
  • difelikefalin 0.25 mg
  • +4 more
  • Scottsdale, Arizona
  • +36 more
Dec 21, 2022

Pruritus, Notalgia Paresthetica Trial in Canada, United States (difelikefalin 2.0 mg, Placebo)

Completed
  • Pruritus
  • Notalgia Paresthetica
  • difelikefalin 2.0 mg
  • Placebo
  • Fort Smith, Arkansas
  • +35 more
Aug 1, 2022

Chronic Kidney Disease Associated Moderate to Severe Pruritus Trial in Worldwide (Nemolizumab, Placebo)

Recruiting
  • Chronic Kidney Disease Associated Moderate to Severe Pruritus
  • Hoover, Alabama
  • +77 more
Dec 13, 2022

Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)

Recruiting
  • Chronic Kidney Diseases
  • Pruritus
  • Difelikefalin 1 mg Oral Tablet
  • Placebo Oral Tablet
  • Huntsville, Alabama
  • +51 more
Dec 21, 2022

Pruritus, Atopic Dermatitis Trial in Canada, United States (difelikefalin 0.25 mg, difelikefalin 0.5 mg, difelikefalin 1.0 mg)

Completed
  • Pruritus
  • Atopic Dermatitis
  • difelikefalin 0.25 mg
  • +3 more
  • Anniston, Alabama
  • +39 more
Mar 30, 2022

Uremic Pruritus Trial in Puerto Rico, United States (CR845)

Completed
Has Results
  • Uremic Pruritus
  • Chula Vista, California
  • +26 more
Sep 21, 2021

Moderate-to-Severe Atopic Dermatitis, Atopic Eczema Trial (dupilumab, Topical emollient (moisturizer))

Not yet recruiting
  • Moderate-to-Severe Atopic Dermatitis
  • Atopic Eczema
  • (no location specified)
Oct 18, 2022

Uremic Pruritus Trial in Worldwide (CR845 0.5 mcg/kg)

Completed
Has Results
  • Uremic Pruritus
  • CR845 0.5 mcg/kg
  • Escondido, California
  • +46 more
Sep 21, 2021

Atopic Dermatitis, Psoriasis, Pruritus Trial in Paris (MBSR (Mindfulness-Based Stress Reduction))

Not yet recruiting
  • Atopic Dermatitis
  • +2 more
  • MBSR (Mindfulness-Based Stress Reduction)
  • Paris, France
    Hôpital Saint-Louis
Aug 11, 2022

Atopic Dermatitis, Eczema Trial (Lebrikizumab)

Not yet recruiting
  • Atopic Dermatitis
  • Eczema
  • Lebrikizumab
  • (no location specified)
Aug 7, 2023

Deucravacitinib in Moderate-to-Severe Plaque Psoriasis in

Recruiting
  • Plaque Psoriasis
  • Selters, Rhineland-Palatinate, Germany
    Dermatologische Spezial- und Schwerpunktpraxis Selters
Oct 23, 2023

Atopic Dermatitis Trial (SAR444656 (KT-474), Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • SAR444656 (KT-474)
  • Placebo
  • (no location specified)
Sep 21, 2023

Atopic Dermatitis Trial (BxC-I17e, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • (no location specified)
Sep 20, 2023

Pruritus Trial (Linerixibat)

Completed
  • Pruritus
  • Orlando, Florida
  • +1 more
Jan 13, 2023

Canadian Patients Receiving Dupixent® for Moderate to Severe

Recruiting
  • Moderate to Severe Atopic Dermatitis
    • Toronto, Ontario, Canada
    • +1 more
    Oct 24, 2023

    Atopic Dermatitis Trial in Sari (Baricitinib 4 MG, Azathioprine 1.5-2.5 mg/kg)

    Not yet recruiting
    • Atopic Dermatitis
    • Baricitinib 4 MG
    • Azathioprine 1.5-2.5 mg/kg
    • Sari, Mazandaran, Iran, Islamic Republic of
      Iran
    Aug 1, 2023

    Dermatitis, Atopic Trial (GSK1070806, Placebo)

    Not yet recruiting
    • Dermatitis, Atopic
    • (no location specified)
    Aug 22, 2023

    Hidradenitis Trial (Amlitelimab, Placebo)

    Not yet recruiting
    • Hidradenitis
    • (no location specified)
    Oct 31, 2023

    Atopic Dermatitis Trial in North Little Rock, Camp Hill, Philadelphia (BxC-I17e, Placebo)

    Recruiting
    • Atopic Dermatitis
    • North Little Rock, Arkansas
    • +2 more
    Sep 20, 2023

    Medical Care of Moderate-to-severe Atopic Dermatitis -

    Recruiting
    • Atopic Dermatitis
      • Bern, Switzerland
        Inselspital, Department of Dermatology
      Apr 17, 2023